Medtronic MDT underwent analysis by 15 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview of their recent ...

During the study period, 400 patients were implanted with SCS devices. In this group, 37% of patients received devices from Boston Scientific, 27.5% from Medtronic, 22.5% from Nevro, 11.8% from ...

The Affera mapping and ablation system with the Sphere-9 catheter [Images courtesy of Medtronic] Medtronic (NYSE:MDT) today said it received FDA approval for its Affera mapping and ablation system ...

24, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug Administration (FDA) approval of the Affera™ Mapping and ...

In 2003, he underwent implantation of a SCS (Itrel III Model 7425, Medtronic Inc., Minneapolis, MN, USA) connected to a quadripolar percutaneous epidural lead (Model 3890, Medtronic) to treat drug ...

During the study period, 400 patients were implanted with SCS devices. In this group, 37% of patients received devices from Boston Scientific, 27.5% from Medtronic, 22.5% from Nevro, 11.8% from Abbott ...

Medtronic has issued a second alert letter to patients regarding shortened battery life of the MiniMed 600 and 700 series insulin pumps. The affected products include the MiniMed 630G, 670G, 770G ...